Phibro Animal Health Stock Performance
| PAHC Stock | USD 18.55 0.09 0.49% |
On a scale of 0 to 100, Phibro Animal holds a performance score of 10. The company holds a Beta of -1.71, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Phibro Animal are expected to decrease by larger amounts. On the other hand, during market turmoil, Phibro Animal is expected to outperform it. Please check Phibro Animal's jensen alpha, potential upside, accumulation distribution, as well as the relationship between the treynor ratio and expected short fall , to make a quick decision on whether Phibro Animal's historical price patterns will revert.
Risk-Adjusted Performance
10 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Phibro Animal Health are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady technical indicators, Phibro Animal exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 0.61 | Five Day Return (1.68) | Year To Date Return 53.42 | Ten Year Return (4.62) | All Time Return 6.76 |
Forward Dividend Yield 0.0259 | Payout Ratio 0.4138 | Forward Dividend Rate 0.48 | Dividend Date 2024-06-26 | Ex Dividend Date 2024-06-05 |
1 | Heres Why Investors Should Buy Phibro Stock Now | 03/20/2024 |
2 | Disposition of 2500 shares by Daniel Bendheim of Phibro Animal at 11.83 subject to Rule 16b-3 | 03/25/2024 |
| Phibro Animal dividend paid on 27th of March 2024 | 03/27/2024 |
3 | Should Value Investors Buy Phibro Animal Health Stock | 04/19/2024 |
4 | EVAH Corp. Opens New Laboratories in Laval | 05/06/2024 |
5 | Phibro Reports Q3 Earnings What Key Metrics Have to Say | 05/09/2024 |
6 | Phibro Animal Health Corp Reports Mixed Q3 Earnings, Updates FY2024 Guidance | 05/10/2024 |
7 | Interpreting Phibro International Revenue Trends | 05/13/2024 |
8 | New Forecasts Heres What Analysts Think The Future Holds For Phibro Animal Health Corporation | 05/14/2024 |
9 | Phibro Animal Health Corporation to Participate in Stifel Dental and Animal Health Conference | 05/20/2024 |
10 | GREY WOLF ANIMAL HEALTH REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS | 05/23/2024 |
| Begin Period Cash Flow | 74.2 M | |
| Total Cashflows From Investing Activities | -74 M |
Phibro |
Phibro Animal Relative Risk vs. Return Landscape
If you would invest 1,327 in Phibro Animal Health on March 1, 2024 and sell it today you would earn a total of 528.00 from holding Phibro Animal Health or generate 39.79% return on investment over 90 days. Phibro Animal Health is currently generating 0.6398% in daily expected returns and assumes 4.5686% risk (volatility on return distribution) over the 90 days horizon. In different words, 40% of stocks are less volatile than Phibro, and 88% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Phibro Animal Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Phibro Animal's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Phibro Animal Health, and traders can use it to determine the average amount a Phibro Animal's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.14
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PAHC | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.57 actual daily | 40 60% of assets are more volatile |
Expected Return
| 0.64 actual daily | 12 88% of assets have higher returns |
Risk-Adjusted Return
| 0.14 actual daily | 10 90% of assets perform better |
Based on monthly moving average Phibro Animal is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Phibro Animal by adding it to a well-diversified portfolio.
Phibro Animal Fundamentals Growth
Phibro Stock prices reflect investors' perceptions of the future prospects and financial health of Phibro Animal, and Phibro Animal fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Phibro Stock performance.
| Return On Equity | 0.0485 | ||||
| Return On Asset | 0.0384 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.08 % | ||||
| Current Valuation | 1.14 B | ||||
| Shares Outstanding | 20.34 M | ||||
| Price To Earning | 11.39 X | ||||
| Price To Book | 1.96 X | ||||
| Price To Sales | 0.54 X | ||||
| Revenue | 977.89 M | ||||
| Gross Profit | 298.24 M | ||||
| EBITDA | 108.49 M | ||||
| Net Income | 32.61 M | ||||
| Cash And Equivalents | 98.67 M | ||||
| Cash Per Share | 2.44 X | ||||
| Total Debt | 509.97 M | ||||
| Debt To Equity | 1.79 % | ||||
| Current Ratio | 2.97 X | ||||
| Book Value Per Share | 6.67 X | ||||
| Cash Flow From Operations | 13.31 M | ||||
| Earnings Per Share | 0.32 X | ||||
| Market Capitalization | 730.68 M | ||||
| Total Asset | 971.4 M | ||||
| Retained Earnings | 260.91 M | ||||
| Working Capital | 409.72 M | ||||
| Current Asset | 342.83 M | ||||
| Current Liabilities | 108.78 M | ||||
About Phibro Animal Performance
To evaluate Phibro Animal Health Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Phibro Animal generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Phibro Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Phibro Animal Health market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Phibro's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 134.16 | 93.87 | |
| Return On Tangible Assets | 0.03 | 0.02 | |
| Return On Capital Employed | 0.10 | 0.15 | |
| Return On Assets | 0.03 | 0.02 | |
| Return On Equity | 0.10 | 0.06 |
Things to note about Phibro Animal Health performance evaluation
Checking the ongoing alerts about Phibro Animal for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Phibro Animal Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Phibro Animal Health appears to be risky and price may revert if volatility continues | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: GREY WOLF ANIMAL HEALTH REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS |
- Analyzing Phibro Animal's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Phibro Animal's stock is overvalued or undervalued compared to its peers.
- Examining Phibro Animal's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Phibro Animal's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Phibro Animal's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Phibro Animal's stock. These opinions can provide insight into Phibro Animal's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phibro Animal Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Phibro Animal Health information on this page should be used as a complementary analysis to other Phibro Animal's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Complementary Tools for Phibro Stock analysis
When running Phibro Animal's price analysis, check to measure Phibro Animal's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phibro Animal is operating at the current time. Most of Phibro Animal's value examination focuses on studying past and present price action to predict the probability of Phibro Animal's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phibro Animal's price. Additionally, you may evaluate how the addition of Phibro Animal to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |
Is Phibro Animal's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Phibro Animal. If investors know Phibro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Phibro Animal listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.16) | Dividend Share 0.48 | Earnings Share 0.32 | Revenue Per Share 24.678 | Quarterly Revenue Growth 0.071 |
The market value of Phibro Animal Health is measured differently than its book value, which is the value of Phibro that is recorded on the company's balance sheet. Investors also form their own opinion of Phibro Animal's value that differs from its market value or its book value, called intrinsic value, which is Phibro Animal's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Phibro Animal's market value can be influenced by many factors that don't directly affect Phibro Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Phibro Animal's value and its price as these two are different measures arrived at by different means. Investors typically determine if Phibro Animal is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Phibro Animal's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.